logo

Health Care News

Share

CENTOGENE Gets FDA Emergency Use Authorization For COVID-19 Molecular Diagnostic Test

Helsinn, MEI Pharma Discontinue Phase 3 Study With Pracinostat After Completing Interim Analysis